» Articles » PMID: 30606720

SIX2 Mediates Late-Stage Metastasis Via Direct Regulation of and Induction of a Cancer Stem Cell Program

Abstract

The capacity for tumor cells to metastasize efficiently is directly linked to their ability to colonize secondary sites. Here we identify Six2, a developmental transcription factor, as a critical regulator of a breast cancer stem cell program that enables metastatic colonization. In several triple-negative breast cancer (TNBC) models, Six2 enhanced the expression of genes associated with embryonic stem cell programs. Six2 directly bound the Srr2 enhancer, promoting expression and downstream expression of , which are both key pluripotency factors. Regulation of by Six2 enhanced cancer stem cell properties and increased metastatic colonization. and expression correlated highly in breast cancers including TNBC, where a Six2 expression signature was predictive of metastatic burden and poor clinical outcome. Our findings demonstrate that a SIX2/SOX2 axis is required for efficient metastatic colonization, underscoring a key role for stemness factors in outgrowth at secondary sites. SIGNIFICANCE: These findings provide novel mechanistic insight into stemness and the metastatic outgrowth of triple-negative breast cancer cells. http://cancerres.aacrjournals.org/content/canres/79/4/720/F1.large.jpg.

Citing Articles

CAV1 inhibits Xc system through IFNGR1 to promote ferroptosis to inhibit stemness and improves anti-PD-1 efficacy in breast cancer.

Liu W, Luo G Transl Oncol. 2024; 50():102149.

PMID: 39395272 PMC: 11736403. DOI: 10.1016/j.tranon.2024.102149.


Prostate Cancer Progression Modeling Provides Insight into Dynamic Molecular Changes Associated with Progressive Disease States.

Chen R, Tang L, Melendy T, Yang L, Goodison S, Sun Y Cancer Res Commun. 2024; 4(10):2783-2798.

PMID: 39347576 PMC: 11500312. DOI: 10.1158/2767-9764.CRC-24-0210.


SIX4 Activation in Inflammatory Response Drives the Transformation of Colorectal Epithelium into Inflammation and Tumor via Feedback-Enhancing Inflammatory Signaling to Induce Tumor Stemness Signaling.

Zhang Z, Huang H, Peng L, Zhou B, Yang H, Tang Z Int J Biol Sci. 2024; 20(12):4618-4634.

PMID: 39309424 PMC: 11414381. DOI: 10.7150/ijbs.93411.


WTAP/IGF2BP3 mediated m6A modification of the EGR1/PTEN axis regulates the malignant phenotypes of endometrial cancer stem cells.

Wang B, Wang Y, Wang W, Wang Z, Zhang Y, Pan X J Exp Clin Cancer Res. 2024; 43(1):204.

PMID: 39044249 PMC: 11264439. DOI: 10.1186/s13046-024-03120-w.


All eyes on Eya: A unique transcriptional co-activator and phosphatase in cancer.

Hughes C, Alderman C, Wolin A, Fields K, Zhao R, Ford H Biochim Biophys Acta Rev Cancer. 2024; 1879(3):189098.

PMID: 38555001 PMC: 11111358. DOI: 10.1016/j.bbcan.2024.189098.


References
1.
Pierce J, Murphy A, Panzer A, de Caestecker C, Ayers G, Neblett D . SIX2 Effects on Wilms Tumor Biology. Transl Oncol. 2014; 7(6):800-11. PMC: 4311027. DOI: 10.1016/j.tranon.2014.09.005. View

2.
Gupta P, Onder T, Jiang G, Tao K, Kuperwasser C, Weinberg R . Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell. 2009; 138(4):645-659. PMC: 4892125. DOI: 10.1016/j.cell.2009.06.034. View

3.
Xi X, Zhuang J, Teng M, Xia L, Yang M, Liu Q . MicroRNA-17 induces epithelial-mesenchymal transition consistent with the cancer stem cell phenotype by regulating CYP7B1 expression in colon cancer. Int J Mol Med. 2016; 38(2):499-506. DOI: 10.3892/ijmm.2016.2624. View

4.
Cerami E, Gao J, Dogrusoz U, Gross B, Sumer S, Aksoy B . The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012; 2(5):401-4. PMC: 3956037. DOI: 10.1158/2159-8290.CD-12-0095. View

5.
Anders C, Carey L . Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer. Clin Breast Cancer. 2009; 9 Suppl 2:S73-81. PMC: 2919761. DOI: 10.3816/CBC.2009.s.008. View